tiprankstipranks
Trending News
More News >
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
Hong Kong Market
Advertisement

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
HK$6.63
HK$20.40B
14.32
104.00%
0 Buy
0 Hold
0 Sell
Moderate Sell
HUTCHMED (China)
258.00p
£2.32B
75.88
-11.64%
0 Buy
0 Hold
0 Sell
Hold
Shanghai Fosun Pharmaceutical (Group) Co
$2.04
$9.22B
13.39
25.15%
0 Buy
1 Hold
0 Sell
Hold
China Resources Pharmaceutical Group Ltd.
€0.59
€3.85B
8.61
-1.67%
0 Buy
0 Hold
0 Sell
Moderate Buy
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
HK$16.00
HK$14.96B
26.93
74.48%
1 Buy
0 Hold
0 Sell
Moderate Buy
CanSino Biologics, Inc. Class H
HK$42.60
HK$12.99B
130.27%
0 Buy
0 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:9989
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
6.63
3.40
105.26%
GB:HCM
HUTCHMED (China)
258.00
-27.00
-9.47%
SFOSF
Shanghai Fosun Pharmaceutical (Group) Co
2.04
0.42
25.93%
DE:640
China Resources Pharmaceutical Group Ltd.
0.59
0.00
0.00%
HK:1558
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
16.00
6.83
74.48%
HK:6185
CanSino Biologics, Inc. Class H
42.60
24.36
133.55%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis